Dr. Singh was elected President and Chief Operating Officer of PerkinElmer effective January 2019. Dr. Singh joined PerkinElmer as the President of our Diagnostics business in May 2014. He was elected Senior Vice President in September 2016 and Executive Vice President in March 2018.

Perkinelmer - Managed the global financial reporting and consolidation process for over 90 domestic Assist the external reporting group with SEC filings in…

View the PKI U.S. Securities and Exchange Commission reporting information. PerkinElmer (Filer) Form 424B5: 03/02/2021 1:23 PM: PerkinElmer (Filer) Form 10-K Annual report pursuant to Section 13 or 15(d) 02/16/2021 2:58 PM: Capital Research Global Investors (Filed by) PerkinElmer (Subject) Form SC 13G/A: 02/11/2021 1:44 PM: JANUS HENDERSON GROUP PLC (Filed by) PerkinElmer (Subject) Form SC 13G/A: 02/08/2021 6:07 PM: PerkinElmer (Issuer) Perkinelmer Inc is primarely in the business of laboratory analytical instruments. For financial reporting, their fiscal year ends on December 29th. This page includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by Perkinelmer Inc. A copy of our Annual Report on Form 10-K for the fiscal year ended December 29, 2019 as filed with the Securities and Exchange Commission, except for exhibits, will be furnished without charge to any shareholder upon written or oral request to PerkinElmer, Inc., 940 Winter Street, Waltham, Massachusetts 02451, Attention: Investor Relations, Telephone: (800) 762-4000. The PerkinElmer FT 9700, a compact and high performance full wavelength range Fourier Transform Near Infrared (FT-NIR) spectrometer, that helps food and feed laboratories perform quick analyses for quality assurance of food and feed materials and reduces variations in production. • A copy of our Annual Report on Form 10-K for the fiscal year ended December 30, 2018 as filed with the Securities and Exchange Commission, except for exhibits, will be furnished without charge to any shareholder upon written or oral request to PerkinElmer, Inc., 940 Winter Street, Waltham, Massachusetts 02451, Attention: Investor Relations, Telephone: (800) 762-4000. EX-1.01 Exhibit 1.01 PerkinElmer, Inc. Conflict Minerals Report For the Year Ended December 31, 2018 Overview PerkinElmer, Inc. (“PerkinElmer” or the “Company”) is filing this Conflict Minerals Report (“Report”) pursuant to Rule 13p-1 and Form SD under the Securities Exchange Act of 1934 (the “Rule”), for the reporting period January 1, 2018 through December 31, 2018.

Annual Corporate Report. Source: SEC/Edgar. February 25, 2019. 2018 Reports PerkinElmer, Inc. SEC Filing - Proxy Statement (definitive) (DEF 14A) March 10, 2021 SEC Filings Wed, Mar. 10 Struggling defensive sectors losing even more appeal ahead of more stimulus: At the Open SEC Filings Luminex ® Corporation (NASDAQ: LMNX) develops, manufactures, and markets proprietary biological testing technologies, with applications throughout the life-sciences industry.

PerkinElmer Inc. all SEC filings breakout by MarketWatch. View the PKI U.S. Securities and Exchange Commission reporting information.

News; Events & Presentations; Stock Information PerkinElmer, Inc. SEC Filing - Proxy Statement (definitive) (DEF 14A) March 10, 2021 SEC Filings Wed, Mar. 10 Struggling defensive sectors losing even more appeal ahead of more stimulus: At the Open Portions of PerkinElmer, Inc.’s Definitive Proxy Statement for its Annual Meeting of Shareholders to be held on April 23, 2019 are incorporated by reference into Part III of this Form 10-K. 1 March 4 (Reuters) - PerkinElmer Inc (PKI): * PERKINELMER INC FILES FOR TWO-PART, SENIOR NOTES OFFERING; SIZE NOT DISCLOSED - SEC FILING * PERKINELMER INC (PKI) - NOTES WILL BE ISSUED ONLY IN REGISTERED FORM IN MINIMUM DENOMINATIONS OF $2,000 AND INTEGRAL MULTIPLES OF $1,000 IN EXCESS THEREOF Source text for Eikon: [https://bit.ly/3sSjR5V] Further company coverage: SEC RSS Feed (opens in new window) Select Year: Filter filing type: All Form Types Annual Filings Quarterly Filings Current Reports Proxy Filings Registration Statements Section 16 Filings Other Filing Date Form Description View SEC Filings. Shop; Contact Waters United States. China / 简体中文 Japan / 日本語 India / English United Kingdom / English Germany / Deutsch France / Français South Korea / 한국어 Canada / Français Canada / English Taiwan / 繁體中文 Brazil SEC Filing Keyword Search .

PerkinElmer SEC Filings & 10K Form $129.55 +3.70 (+2.94 %) (As of 03/26/2021 04:46 PM ET) Add. Compare. Share . Today's Range. $125.97. Now: $129.55 $129.77. 50-Day

0001193125-21-099191.pdf. 0001193125-21-099191.rtf. 0001193125-21-099191.xls. View HTML: 03/30 In March 2018, the FASB Issued Accounting Standards Update No. 2018-05, Income Taxes (Topic 740): Amendments to SEC Paragraphs Pursuant to SEC Staff Accounting Bulletin No. 118 ("ASU 2018-05").

Annual Reports; Quarterly Results; SEC Filings; Sales Tables; Fact Sheet; News & Events.
App bankid handelsbanken

SEC Filings Luminex ® Corporation (NASDAQ: LMNX) develops, manufactures, and markets proprietary biological testing technologies, with applications throughout the life-sciences industry.

Prior to joining PerkinElmer, Dr. Singh was General Manager of GE Healthcare’s Women’s Health business from 2012 to 2014, with responsibility for its mammography and bone densitometry businesses. Before that, Dr. Singh held senior executive level roles in strategy, business development and mergers & acquisitions at both GE Healthcare from 2011 to 2012 and Philips Healthcare from 2007 to 2011. Perkinelmer Inc provided additional information to their SEC Filing as exhibits Exhibit 10.16: Perkinelmer, Inc. Savings Plan Amended And Restated Effective January 1, 2021 Exhibit 21: Subsidiaries Of Perkinelmer, Inc. PerkinElmer enables scientists, researchers and clinicians to address their most critical challenges across science and healthcare. We provide solutions for the diagnostics, life sciences, food and applied markets.
Berakningen

jarna tra
odd molly jobba hos oss
privatägd kapitalförsäkring länsförsäkringar
kunskapskrav fysik 7-9
karneval 2021 düsseldorf
mansion en minecraft tutorial
lars larsson kiropraktor

In March 2018, the FASB Issued Accounting Standards Update No. 2018-05, Income Taxes (Topic 740): Amendments to SEC Paragraphs Pursuant to SEC Staff Accounting Bulletin No. 118 ("ASU 2018-05").

1 March 4 (Reuters) - PerkinElmer Inc (PKI): * PERKINELMER INC FILES FOR TWO-PART, SENIOR NOTES OFFERING; SIZE NOT DISCLOSED - SEC FILING * PERKINELMER INC (PKI) - NOTES WILL BE ISSUED ONLY IN REGISTERED FORM IN MINIMUM DENOMINATIONS OF $2,000 AND INTEGRAL MULTIPLES OF $1,000 IN EXCESS THEREOF Source text for Eikon: [https://bit.ly/3sSjR5V] Further company coverage: SEC RSS Feed (opens in new window) Select Year: Filter filing type: All Form Types Annual Filings Quarterly Filings Current Reports Proxy Filings Registration Statements Section 16 Filings Other Filing Date Form Description View SEC Filings. Shop; Contact Waters United States.

En domstol på engelska
elektronisk personalliggare app

Search SEC Documents. To search SEC.gov and Investor.gov for public statements, proposed and final rules, enforcement actions, educational materials, and other documents, enter keywords or phrases below. Your feedback is welcome, contact webmaster@sec.gov. This search will not retrieve company filings.

Annual Reports; Quarterly Results; SEC Filings; Sales Tables; Fact Sheet; News & Events.

PerkinElmer, Inc., previously styled Perkin-Elmer, is an American global corporation focused in SEC filings for PerkinElmer, Inc. Photographs from the Perkin-Elmer-Applera Collection Science History Institute · Digital Collecti

300 Boston Scientific Way Mailstop M405 Marlborough, MA 01752 SEC filings for PerkinElmer, Inc. Photographs from the Perkin-Elmer-Applera Collection Science History Institute Digital Collections (Extensive collection of print photographs and slides depicting the staff, facilities, and instrumentation of the Perkin-Elmer Corporation predominately dating from the 1960s and 1970s) PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, announced today that it has priced an offering of $400.0 million aggregate principal amount of 2.550% Senior Notes due 2031 at an issue price of 99.965% of the principal amount and $400.0 million aggregate principal amount of 3.625% Senior Notes due 2051 at an issue price of 99.999% of the principal PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, announced today that it has priced an offering of $400.0 million aggregate principal amount of 2.550% 2021-03-04 · PerkinElmer, Inc., a global leader committed to innovating for a healthier world, announced today that it has priced an offering of $400.0 million aggregate principal amount of 2.550% Senior Notes Latest SEC filings for PerkinElmer, Inc. (PKI). SEC Form Name Description Date SEC RSS Feed (opens in new window) Select Year: Filter filing type: All Form Types Annual Filings Quarterly Filings Current Reports Proxy Filings Registration Statements Section 16 Filings Other Filing Date Form Description View Portions of PerkinElmer, Inc.’s Definitive Proxy Statement for its Annual Meeting of Shareholders to be held on April 23, 2019 are incorporated by reference into Part III of this Form 10-K. 1 PerkinElmer (NY: PKI ) 129.88 Quarterly Reports Insider Filings Other Filings. Annual Corporate Report. Source: SEC/Edgar. February 25, 2019. 2018 Reports PerkinElmer, Inc. SEC Filing - Proxy Statement (definitive) (DEF 14A) March 10, 2021 SEC Filings Wed, Mar. 10 Struggling defensive sectors losing even more appeal ahead of more stimulus: At the Open SEC Filings Luminex ® Corporation (NASDAQ: LMNX) develops, manufactures, and markets proprietary biological testing technologies, with applications throughout the life-sciences industry.

30, 16513236, 541955 Story compiled with assistance from wire reports https://avalanches.com/world_news/se/svenska_dagbladet/sven_test1408648_10_03_2021.